Amiodarone Should Be the First-Line Antiarrhythmic Treatment for Pulseless Ventricular Tachycardia and Ventricular Fibrillation

Ann Emerg Med. 2025 May;85(5):447-448. doi: 10.1016/j.annemergmed.2024.09.020.

¹ Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines, Jr. VA Hospital, Hines, IL; Department of Emergency Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL. Electronic address: megan.a.rech@gmail.com.
² Department of Emergency Medicine, Rush University Medical Center, Chicago, IL.

No abstract available